Ree rate13 Apr 2026 13:05
And also £1.4mln potential contracts due according to presentation
With just a £2mln cap and only 450mln shares ( many bio tech peers have 1.5-2.5bln shares eg apta gdr etc) and with £650,000 from the recent investment and c £200-300k left from before that is nearly 50% pf market cap in cash
Also the new TR1 holders have
Already here
1) increased TR1 holdings to 20%+ thus decreasing available shares
2) pressured board to increase placing by nearly 35%
3) making BOD more accountable to share holders
4) introduced HNWs to the share register
5) thus even the 0.4p placing has been left behind with share price 20% higher whereas in past the churn lasted 3-6mths